{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:52:37Z","timestamp":1740109957152,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jad.2015.12.060","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T17:03:28Z","timestamp":1451581408000},"page":"381-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone"],"prefix":"10.1016","volume":"193","author":[{"given":"Dong-Jing","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Turkoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A.","family":"Bossie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiren","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Alphs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1994","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","key":"10.1016\/j.jad.2015.12.060_bib1"},{"key":"10.1016\/j.jad.2015.12.060_bib2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association [APA], 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5\u00ae), pp. 1\u2013991.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"1\u20133","key":"10.1016\/j.jad.2015.12.060_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2010.09.011","article-title":"Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study","volume":"129","author":"Berwaerts","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"1\u20132","key":"10.1016\/j.jad.2015.12.060_bib4","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jad.2010.06.030","article-title":"Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose-response study","volume":"136","author":"Berwaerts","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.jad.2015.12.060_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.schres.2010.02.1027","article-title":"Frequency of schizoaffective disorder diagnosis in an international patient population with psychotic disorders using the Mini-International Neuropsychaitric Interview","volume":"118","author":"Canuso","year":"2010","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.jad.2015.12.060_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4088\/JCP.09m05564yel","article-title":"A randomized, double-blind, placebo-controlled study of 2 dose ranges of paliperidone extended-release in the treatment of subjects with schizoaffective disorder","volume":"71","author":"Canuso","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2015.12.060_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/JCP.0b013e3181eeb600","article-title":"Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and\/or mood stabilizers","volume":"30","author":"Canuso","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.12.060_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/NDT.S12612","article-title":"Role of paliperidone extended-release in treatment of schizoaffective disorder","volume":"6","author":"Canuso","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1\u20133","key":"10.1016\/j.jad.2015.12.060_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2007.03.003","article-title":"Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study","volume":"93","author":"Davidson","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2015.12.060_bib10","unstructured":"European Medicines Agency and Committee for Medicinal Products for Human Use (CHMP), 2012. Guideline on Clinical Investigation of Medicinal Products, Including Depot Preparations in the Treatment of Schizophrenia. \u3008http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2012\/10\/WC500133437.pdf\u3009."},{"issue":"3","key":"10.1016\/j.jad.2015.12.060_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4088\/JCP.14m09416","article-title":"Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder","volume":"76","author":"Fu","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2015.12.060_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/JCP.0b013e31814f30b1","article-title":"Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression","volume":"27","author":"Furukawa","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.12.060_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2015.12.060_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2006.09.012","article-title":"Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial","volume":"90","author":"Kane","year":"2007","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.jad.2015.12.060_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.jad.2015.12.060_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.4088\/JCP.09m05874yel","article-title":"Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone","volume":"72","author":"Kemp","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2015.12.060_bib17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1176\/ps.46.12.1254","article-title":"Heavy utilization of inpatient and outpatient services in a public mental health service","volume":"46","author":"Kent","year":"1995","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.jad.2015.12.060_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JCP.0b013e31802dda4a","article-title":"Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"27","author":"Kramer","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.jad.2015.12.060_bib19","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.npp.1301147","article-title":"Linking the PANSS, BPRS, and CGI: clinical implications","volume":"31","author":"Leucht","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jad.2015.12.060_bib20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.biopsych.2007.01.017","article-title":"Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study","volume":"62","author":"Marder","year":"2007","journal-title":"Biol. Psychiatry."},{"issue":"2","key":"10.1016\/j.jad.2015.12.060_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/ps.2009.60.2.210","article-title":"Treatment patterns for schizoaffective disorder and schizophrenia among Medicaid patients","volume":"60","author":"Olfson","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2015.12.060_bib22","unstructured":"Ortho-McNeil-Janssen Pharmaceuticals, 2007. Inc. Invega (paliperidone) extended-release tablets. 2011. Titusville, NJ"},{"issue":"1","key":"10.1016\/j.jad.2015.12.060_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jad.2013.01.047","article-title":"Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression","volume":"150","author":"Turkoz","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2015.12.060_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-5618.2010.00815.x","article-title":"A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder","volume":"12","author":"Vieta","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2015.12.060_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715309484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715309484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T08:54:25Z","timestamp":1621068865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715309484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":25,"alternative-id":["S0165032715309484"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.12.060","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.12.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}